Does use of tetracyclic antidepressant—mirtazapine reduce cancer risk in depression patients?

We conducted a nested case‐control study to evaluate the association between risk of cancer and mirtazapine use in depression patients in Taiwan.

[1]  A. Jemal,et al.  Annual Report to the Nation on the status of cancer, 1975‐2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer , 2014, Cancer.

[2]  W. Ahrens,et al.  Smoking addiction and the risk of upper‐aerodigestive‐tract cancer in a multicenter case–control study , 2013, International journal of cancer.

[3]  F. Blyth,et al.  Psychotropic drug use and alcohol drinking in community-dwelling older Australian men: the CHAMP study. , 2013, Drug and alcohol review.

[4]  J. Banales,et al.  Alcohol consumption on pancreatic diseases. , 2013, World journal of gastroenterology.

[5]  Yongzhi Yang,et al.  Obesity and Risk of Colorectal Cancer: A Systematic Review of Prospective Studies , 2013, PloS one.

[6]  F. Sung,et al.  Non-apnea sleep disorders will increase subsequent liver cancer risk--a nationwide population-based cohort study. , 2012, Sleep medicine.

[7]  Jeng-Jong Hwang,et al.  Mirtazapine Inhibits Tumor Growth via Immune Response and Serotonergic System , 2012, PloS one.

[8]  F. Sung,et al.  A population-based nested case-control study in taiwan: use of 5α-reductase inhibitors did not decrease prostate cancer risk in patients with benign prostate hyperplasia. , 2012, The oncologist.

[9]  F. Sung,et al.  A Nationwide Population-Based Cohort Study: Will Anxiety Disorders Increase Subsequent Cancer Risk? , 2012, PloS one.

[10]  P. Doraiswamy,et al.  Review of the use of mirtazapine in the treatment of depression , 2011, Expert opinion on pharmacotherapy.

[11]  J. Myers,et al.  Antidepressants and Breast and Ovarian Cancer Risk: A Review of the Literature and Researchers' Financial Associations with Industry , 2011, PloS one.

[12]  F. Sung,et al.  The Analysis of Depression and Subsequent Cancer Risk in Taiwan , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[13]  J. Korf,et al.  Antidepressive Effect of Mirtazapine in Post-Myocardial Infarction Depression Is Associated with Soluble TNF-R1 Increase: Data from the MIND-IT , 2011, Neuropsychobiology.

[14]  R. Kast.  Profound blockage of CXCR4 signaling at multiple points using the synergy between plerixafor, mirtazapine, and clotrimazole as a new glioblastoma treatment adjunct. , 2010, Turkish neurosurgery.

[15]  H. Sørensen,et al.  Antidepressant use and colorectal cancer risk: a Danish population-based case–control study , 2010, British Journal of Cancer.

[16]  C. Limatola,et al.  CXCL12-induced glioblastoma cell migration requires intermediate conductance Ca2+-activated K+ channel activity. , 2010, American journal of physiology. Cell physiology.

[17]  A. Jemal,et al.  Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates , 2010, Cancer.

[18]  E. Castigli,et al.  Histamine hyperpolarizes human glioblastoma cells by activating the intermediate-conductance Ca2+-activated K+ channel. , 2009, American journal of physiology. Cell physiology.

[19]  Ali H Mokdad,et al.  Depression and anxiety in the United States: findings from the 2006 Behavioral Risk Factor Surveillance System. , 2008, Psychiatric services.

[20]  D. Ciraulo,et al.  Differences between daily smokers, chippers, and nonsmokers with co-occurring anxiety and alcohol-use disorders. , 2008, Addictive behaviors.

[21]  J. Wardle,et al.  Do stress-related psychosocial factors contribute to cancer incidence and survival? , 2008, Nature Clinical Practice Oncology.

[22]  Lin Jia,et al.  Effect of antidepressants on body weight, ethology and tumor growth of human pancreatic carcinoma xenografts in nude mice. , 2008, World journal of gastroenterology.

[23]  T. Urbánek,et al.  Mirtazapine in the treatment of adolescent anorexia nervosa , 2008, European Child & Adolescent Psychiatry.

[24]  Sung-Wan Kim,et al.  Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression , 2008, Psychiatry and clinical neurosciences.

[25]  F. Buntinx,et al.  A meta-analysis on depression and subsequent cancer risk , 2007, Clinical practice and epidemiology in mental health : CP & EMH.

[26]  Hong‐Tai Chang,et al.  The antidepressant mirtazapine-induced cytosolic Ca2+ elevation and cytotoxicity in human osteosarcoma cells. , 2006, The Chinese journal of physiology.

[27]  H. Arimochi,et al.  Characterization of cytotoxic actions of tricyclic antidepressants on human HT29 colon carcinoma cells. , 2006, European journal of pharmacology.

[28]  E. Leinonen,et al.  A review of the pharmacological and clinical profile of mirtazapine. , 2006, CNS drug reviews.

[29]  .. R.E.Kast,et al.  Current Drugs Available Now for Interleukin-6 Suppression as Treatment Adjunct in Glioblastoma: Anakinra, Aprepitant, Mirtazapine and Olanzapine , 2006 .

[30]  S. Heckbert,et al.  Antidepressant use and breast cancer risk , 2005, Breast Cancer Research and Treatment.

[31]  J. Marrero,et al.  Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. , 2005, Journal of hepatology.

[32]  D B Richardson,et al.  An incidence density sampling program for nested case-control analyses , 2004, Occupational and Environmental Medicine.

[33]  M. Rietschel,et al.  Population pharmacokinetic analysis of mirtazapine , 2004, European Journal of Clinical Pharmacology.

[34]  D. Singer,et al.  Trends in Prescribing of Selective Serotonin Reuptake Inhibitors and Other Newer Antidepressant Agents in Adult Primary Care. , 2003, Primary care companion to the Journal of clinical psychiatry.

[35]  W. Hsiao,et al.  Does universal health insurance make health care unaffordable? Lessons from Taiwan. , 2003, Health affairs.

[36]  M. Cataldi,et al.  Apoptosis induced in neuronal cells by oxidative stress: role played by caspases and intracellular calcium ions. , 2003, Toxicology letters.

[37]  J. Olsen,et al.  Antidepressant medications and risk for cancer. , 2000, Epidemiology.

[38]  P. Goodnick,et al.  Mirtazapine in major depression with comorbid generalized anxiety disorder. , 1999, The Journal of clinical psychiatry.

[39]  F. LaBella,et al.  Enhancement of tumor growth by drugs with some common molecular actions , 1996, Molecular carcinogenesis.

[40]  M. Cotterchio,et al.  Do antidepressants cause, promote, or inhibit cancers? , 1995, Journal of clinical epidemiology.

[41]  H. Iishi,et al.  Enhancement by the tricyclic antidepressant, desipramine, of experimental carcinogenesis in rat colon induced by azoxymethane. , 1993, Carcinogenesis.

[42]  J. Ligibel,et al.  Obesity and its impact on breast cancer: tumor incidence, recurrence, survival, and possible interventions. , 2013, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

[43]  Jin-hai Tang,et al.  Active and passive smoking, and alcohol drinking and breast cancer risk in chinese women. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[44]  P. Hartmann,et al.  Mirtazapine: a newer antidepressant. , 1999, American family physician.

[45]  J. Gorman.  Mirtazapine: clinical overview. , 1999, The Journal of clinical psychiatry.

[46]  R. Mcgee,et al.  Depression and the development of cancer: a meta-analysis. , 1994, Social science & medicine.